-
Rage Biotech Opens With Goal of Treating CF and Similar Lung Diseases
Rage Biotech, building on research done at Australian universities, will focus on a protein that amplifies inflammation to treat inflammatory lung diseases. Read more about this research here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.